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Sarah Ratzel1 and Sara B. Cullinan2Enhancer Variation at GALNT2 Influences HDL-C
Roman et al., page 801
Genome-wide association studies (GWASs) have produced
vast numbers of SNPs associated with various traits; how-
ever, the nature of many of these signals remains unclear.
Determining the true functional variants underlying the
signal and the consequences of variation at these sites re-
quires experimental validation of each of these GWAS
loci. In this issue, Roman et al. fine mapped a region
near GALNT2, a gene whose protein product is involved
in high-density lipoprotein cholesterol (HDL-C) meta-
bolism and associated with blood lipid and cholesterol
levels. At least two variants in linkage disequilibrium
with the tag SNP appear to alter transcription-factor bind-
ing and GALNT2 expression. Moreover, analysis of mRNA-
expression data derived from hepatic cells suggests that
these SNPs are associated with increased HDL-C and a
slight increase in GALNT2 expression in an allele-depen-
dent manner. Together, these results demonstrate that
multiple regulatory variants near GALNT2 might explain
the GWAS signal and suggest that future work in deter-
mining how GALNT2 influences HDL particle size could
be useful in understanding blood lipids in humans. As
additional studies investigating the biological role of
GWAS SNPs become available, our understanding of
many complex diseases will be enriched, perhaps leading
to previously unexplored avenues of prevention and
therapy.The Search for Psoriasis Genetic Architecture
Stuart et al., page 816
Psoriasis is a common inflammatory disorder of the skin,
and nearly one-third of affected individuals will go on to
develop psoriatic arthritis, a disease also affecting the
musculoskeletal system. Although it is clear from twin
studies that the heritability of psoriatic arthritis differs
from that of cutaneous-only psoriasis, the underlying
genetic differences remain incompletely understood.
In this issue, Stuart et al. performed a series of analyses
aimed at addressing this question. Overall, their work
identified five independent variants that are diff-
erentially associated with psoriatic arthritis and cuta-
neous-only psoriasis. One signal, in chromosomal region1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The American1p36.23, was associated with cutaneous-only psoriasis,
but not psoriatic arthritis. The others were associated
with both conditions, but to differing degrees. Most
notably, harboring a variant that alters a portion of the
HLA-B antigen-binding groove halves the risk of progres-
sion to psoriatic arthritis. Data mining and literature
searches are able to suggest plausible biological pathways
that might be involved in these differing genetic
associations, but additional work—genetic, genomic,
and experimental—will be required for identifying caus-
ative variants and gaining clear insights into the discrete
etiologies.Modifying 22q11.2 Deletion Syndrome
Guo et al., page 869
Genetic modifiers, secondary variants that alter the
phenotype of the most penetrant variant, are often
invoked to explain differences in phenotypic expressiv-
ity and heterogeneity. For example, modifiers have
been proposed to explain why some, but not all, indi-
viduals with 22q11.2 deletion syndrome (22q11DS)
develop severe congenital heart defects (CHDs). In this
issue, Guo et al. compared the variants identified from
exome sequencing of 22q11DS-affected individuals
with and without CHDs. Variants in JMJD1C and
RREB1 were identified significantly more often in indi-
viduals with 22q11DS and CHDs. Both JMJD1C and
RREB1 are involved in chromatin modification, suggest-
ing that variation in histone modification might alter
the risk of developing CHDs in 22q11DS. In total, about
20% of the 22q11DS cohort with CHDs also harbored
variants in genes whose protein products contribute to
histone modification; by contrast, no enrichment was
detected in control subjects without CHDs. These find-
ings are consistent with the reports of mutations in his-
tone-modifying genes in individuals with undiagnosed
syndromic or non-syndromic CHDs, supporting the
role of this function for heart development in general.
As larger cohorts of individuals harboring rare mutations
in the same gene but presenting with a spectrum of
different phenotypes are amassed, the potential to un-
cover modifiers increases and could provide an opportu-
nity to better understand the genetic interplay underly-
ing a given disease.y of Human Genetics. All rights reserved.
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Managing Manganese Deficiency
Boycott et al., page 886; Park et al., page 894
Divalent cations serve as cofactors for numerous cellular
processes. Manganese, for example, is essential for the ac-
tivity of several families of enzymes and transcription fac-
tors. Whereas manganese overload has been associated
with severe neurological symptoms, manganese deficiency
in animals results in abnormal development. In this issue,
Boycott et al. and Park et al. report the identification ofmu-
tations in SLC39A8 in individuals with intellectual
disability and cerebral atrophy. SLC39A8 encodes ZIP8, a
transmembrane protein that is required for transport of
manganese, zinc, cadmium, cobalt, and iron across the
plasma membrane, as well as the membranes of intracel-
lular organelles. Slc38a8/ mice displayed embryonic
lethality, indicating that complete loss of ZIP8 function is
incompatible with life. Biochemical analyses revealed
abnormally low blood manganese and zinc levels, as well
as N-glycan patterns consistent with a congenital disorder
of glycosylation. More in-depth analysis revealed a defect
in galactosylation, leading the authors to test whether die-
tary galactose supplementation could improve the health
of affected individuals. Indeed, the increased galactose
brought about immediate improvements in glycosylation,
suggesting that early diagnosis and dietary supplementa-
tion, perhaps with both galactose and manganese, could
ameliorate several of the phenotypes associated with
SLC39A8 deficiency.772 The American Journal of Human Genetics 97, 771–772, DecembDisrupting Geminin Destruction
Burrage et al., page 904
Meier-Gorlin syndrome (MGS) is an autosomal-recessive
disorder caused by mutations that alter the function of
proteins involved in DNA replication. Shared characteris-
tics of affected individuals include primordial dwarfism,
abnormal patellae, and microtia. Now, in this issue, Bur-
rage et al. describe three individuals who have auto-
somal-dominant MGS and each harbor de novo mutations
in GMNN. GMNN encodes geminin, which inhibits DNA
replication through its interactions with CDT1. Geminin
activity is highest during the G2 and M phases of the cell
cycle; it is degraded during themetaphase-anaphase transi-
tion. Strikingly, each of the identified mutations is pre-
dicted to alter geminin’s destruction box, the amino acid
sequence that targets its degradation. Indeed, the variant
forms of the protein initiate at an internal methionine
and display increased stability. The authors propose that
themutant alleles operate through a gain-of-function para-
digm in which DNA replication is improperly regulated.
With these findings, Burrage et al. confirm that MGS re-
sults from aberrant regulation of DNA replication—
through either decreased activity in proteins that drive
replication or increased activity of inhibitors. These results
provide new insight into MGS and should be of interest to
clinicians and basic researchers, who through additional
experimentation should be able to obtain a more complete
understanding of these mutations at a molecular level.er 3, 2015
